community-acquired pneumonia , CAP (Abkürzung)

They may also increase the risk of community-acquired pneumonia in adults and children.

To these older men and women, it seems that community-acquired pneumonia is no longer a friend.

The global economic cost of community-acquired pneumonia has been estimated at $17 billion annually.

Long-term outcome after community-acquired pneumonia, however, has not been as well investigated.

During the 11-month interval, 147 patients with community-acquired pneumonia were admitted to the two hospitals.

A prediction rule to identify low-risk patients with community-acquired pneumonia.

In community-based practices, the following classification of community-acquired pneumonia is now commonly used.

Short-term mortality among patients admitted to hospital with community-acquired pneumonia has ranged from 6% to 33%.

Causes of treatment failure in adults with community-acquired pneumonia (Table 2.8)

In Canada, 16% of community-acquired pneumonia among adults has been attributed to pneumococcus.

In a prospective cohort study 141 consecutive patients were admitted to hospital with community-acquired pneumonia.

Guidelines for the management of community-acquired pneumonia: current recommendations and antibiotic selection issues.

The causes, microbiology, treatment and prognosis are different from those of community-acquired pneumonia.

No previous study has identified predictors of outcome beyond 12 months among patients admitted to hospital with community-acquired pneumonia.

Old age should not be a sole criterion for withholding aggressive treatment of community-acquired pneumonia.

These results, therefore, may not apply to persons with community-acquired pneumonia who are managed as outpatients.

Home-based treatment was also evaluated as an option in those with mild community-acquired pneumonia.

These results suggest that underlying health is much more important than age in determining prognosis after hospital care with community-acquired pneumonia.

Overall, Streptococcus pneumoniae is the most common cause of community-acquired pneumonia worldwide.

Is chest physical examination adequate in detecting community-acquired pneumonia?

In the United States, community-acquired pneumonia affects 5.6 million people per year, and ranks 6th among leading causes of death.

Most important, we know of no other study of community-acquired pneumonia to have obtained follow-up over 2 years after discharge.

The disease is commonly misdiagnosed as bacterial community-acquired pneumonia.

It has been estimated that one out of every 1,000 adults is hospitalized each year for treatment of community-acquired pneumonia.

It is thus distinguished from community-acquired pneumonia.